Clinical trial for Hepatic Cancer
Official title Immunohistochemical Algorithm for the Diagnosis and Classification of Hepatocellular Carcinomas With TERT, TP53 and CTNNB1 Mutation
ClinicalTrials.gov ID: NCT06718153
What this study is testing
- What it's testing
- The study aims to create a simple tissue test that tells doctors which liver cancers should get detailed gene sequencing for prognosis.
- Who it's for
- People with liver cancer who are having their tumor removed surgically.
- What's involved
- Researchers will apply special stains to the removed tumor tissue and compare the results to genetic testing.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Age ≥18 years
- Patients resected for HCC
- Availability of NGS data
- Availability of paraffin material for immunohistochemistry investigations
You likely can't join if
- None
The study team makes the final eligibility decision.
Where it is enrolling
- Bologna, Italy
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part, but confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
This study is enrolling now at Bologna, Italy. Enter your location above to see the nearest enrolling site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool that is independent of the study sponsor. Details come from ClinicalTrials.gov. The study team decides eligibility, and your own doctor gives medical advice.